Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients

NCT00336895 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Immunosuppression

Interventions

DRUG: Myfortic

Sponsor

University of Pittsburgh

Collaborators

[object Object]